Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE: BRV-PV Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Niger
NCT02145000Phase 3Completed
- Sponsor
- Illumina
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Rotasil in rotavirus gastroenteritis, sponsored by Illumina. Started Jun 2014; status: completed.
02
Drugs
Rotasil
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT02145000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145000.